Hexagon Nutrition Ltd.

•

hexagonnutrition.comBSE: 544785NSE: HEXAGON

Market Cap₹ 840 Cr.

Current Price

High / Low₹ 78 / 48

Stock P/E22.1

Book Value₹ 20

Price to Book3.44

Dividend Yield0.00 %

ROCE17.4 %

ROE14.1 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Latest quarter profit grew 939.8% YoY, showing strong momentum
Company has consistently been profitable over the last 5 years
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.44x)
Institutional investors have been accumulating - FII+DII up 6.7pp
Company comfortably covers its interest (9.5x coverage)
Company generates healthy free cash flow

CONS

Company has a low return on equity of 8.6% over last 3 years
Company has a low return on capital employed of 11.5%
Company has delivered a poor profit growth of 5.6% over past five years
Recurring exceptional / one-off items are inflating headline profit
Though reporting repeated profits, the company pays out little dividend (0.0%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	HEXAGON	68.30	22.13	839.53	0.00	8.07	—	104.31	-2.08	17.37	11.25

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2025	Jun 2025	Mar 2026	Jun 2026
	107	73	115	104
	94	66	100	96
Operating Profit	13	7	15	8
OPM %	11.88%	9.72%	13.08%	8.11%
	1	1	4	2
Interest	1	1	1	1
Depreciation	2	2	3	2
Profit before Tax	10	8	15	11
Tax %	22.63%	23.80%	29.29%	23.85%
Net Profit	0	6	11	8
	0.70	0.58	0.99	0.67

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	122	139	211	236	204	211	271	279	298	325	399
	101	121	196	205	176	177	235	256	273	284	355
Operating Profit	21	18	15	31	28	34	36	22	24	41	43
OPM %	17.61%	13.02%	7.04%	13.23%	13.56%	16.09%	13.38%	8.03%	8.19%	12.58%	10.84%
	1	1	-1	-0	9	6	5	-2	7	6	8
Interest	4	3	3	4	3	3	2	3	4	4	4
Depreciation	5	7	7	7	7	6	7	8	8	9	10
Profit before Tax	13	10	4	20	26	31	32	9	20	34	45
Tax %	42.72%	38.65%	19.26%	21.69%	29.63%	26.59%	28.16%	38.20%	37.37%	27.70%	25.45%
Net Profit	7	6	3	15	19	23	23	6	12	24	33
EPS	0.00	0.00	0.00	0.00	1.51	1.86	1.90	0.47	1.10	2.20	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	8.93%	7.25%	7.11%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: 14%
5 Years:: 10%
3 Years:: 6%

COMPOUNDED PROFIT GROWTH

10 Years:: 14%
5 Years:: 6%
3 Years:: 1%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: 13%
5 Years:: 13%
3 Years:: 9%
Last Year:: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	11	11	11	11	11	11	11	11	11	11
	41	60	63	77	93	115	136	140	153	171
	28	25	47	27	32	19	38	51	37	25
Trade Payables	16	30	43	45	32	35	33	45	20	19
	11	24	27	30	30	31	36	39	27	32
Total Liabilities	106	150	191	191	198	211	255	286	248	259
	47	47	51	53	50	51	55	56	65	64
Capital Work in Progress	2	1	5	1	1	1	7	4	2	3
	0	5	0	7	12	18	23	30	19	34
	15	35	57	41	54	60	61	88	79	61
	0	0	0	0	0	0	0	0	49	60
Cash & Bank	3	15	8	7	24	22	28	22	24	20
	40	47	71	82	58	59	81	86	10	16
Total Assets	106	150	191	191	198	211	255	286	248	259

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	15	5	-17	20	28	37	20	4	23	38
Cash from Investing	-9	-12	-10	-12	-10	-9	-21	-19	4	-23
Cash from Financing	-4	22	23	-19	-1	-18	16	7	-19	-19
	-2	12	-7	-0	13	1	6	-12	8	-4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

Shareholding Pattern

Numbers in percentages

	Sep 2014	Jul 2015	Aug 2016	Sep 2017	Sep 2018	Aug 2019	Jun 2026
	0.00	100.00	100.00	100.00	100.00	99.67	64.29
	0.00	0.00	0.00	0.00	0.00	0.00	0.29
	0.00	0.00	0.00	0.00	0.00	0.00	6.42
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	100.00	0.00	0.00	0.00	0.00	0.33	28.99

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-01

General Updates

2026-09-01 - Hexagon Nutrition Limited has informed the Exchange about General Updates

2026-09-01

General Updates

2026-09-01 - Hexagon Nutrition Limited has informed the Exchange about General Updates

2026-09-01

Copy of Newspaper Publication

2026-09-01 - Hexagon Nutrition Limited has informed the Exchange about Copy of Newspaper Publication - Information regarding 33rd Annual General Meeting of the Company to be held through Video Conferencing / Other Audio Visual Means and Remote e-voting

2026-08-31

Shareholders meeting

2026-08-31 - Hexagon Nutrition Limited has informed the Exchange regarding Notice of undefined to be held on September 22, 2026

2026-08-26

Copy of Newspaper Publication

2026-08-26 - Hexagon Nutrition Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-19

Updates

2026-08-19 - Hexagon Nutrition Limited has informed the Exchange regarding 'Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011, Ms. Anuradha Kelkar, Promoter group member of the Company acquired 15,000 Equity shares'.

2026-08-19

Updates

2026-08-19 - Hexagon Nutrition Limited has informed the Exchange regarding 'Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011, Mr. Vikram Kelkar, Promoter and Managing Director of the Company acquired 16,300 Equity shares '.

2026-08-19

Updates

2026-08-19 - Hexagon Nutrition Limited has informed the Exchange regarding 'Disclosure Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011, this is to inform you that Dr. Nikhil Kelkar, Promoter and Joint Managing Director of the Company acquired 16,400 Equity shares '.

2026-08-18

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-18 - Hexagon Nutrition Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for HEXAGON

Loading news…

🤖

AI Stock Analyst

Hexagon Nutrition Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

HEXAGON

68.30

22.13

839.53

0.00

8.07

—

104.31

-2.08

17.37

11.25

Mar 2025

Jun 2025

Mar 2026

Jun 2026

107

115

104

100

Operating Profit

OPM %

11.88%

9.72%

13.08%

8.11%

Interest

Depreciation

Profit before Tax

Tax %

22.63%

23.80%

29.29%

23.85%

Net Profit

0.70

0.58

0.99

0.67

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

122

139

211

236

204

211

271

279

298

325

399

101

121

196

205

176

177

235

256

273

284

355

Operating Profit

OPM %

17.61%

13.02%

7.04%

13.23%

13.56%

16.09%

13.38%

8.03%

8.19%

12.58%

10.84%

-1

-0

-2

Interest

Depreciation

Profit before Tax

Tax %

42.72%

38.65%

19.26%

21.69%

29.63%

26.59%

28.16%

38.20%

37.37%

27.70%

25.45%

Net Profit

EPS

0.00

1.51

1.86

1.90

0.47

1.10

2.20

—

Dividend Payout %

0.00%

8.93%

7.25%

7.11%

0.00%

—

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

115

136

140

153

171

Trade Payables

Total Liabilities

106

150

191

198

211

255

286

248

259

Capital Work in Progress

Cash & Bank

Total Assets

106

150

191

198

211

255

286

248

259

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

-17

Cash from Investing

-9

-12

-10

-12

-10

-9

-21

-19

-23

Cash from Financing

-4

-19

-1

-18

-19

-2

-7

-0

-12

-4

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Sep 2014

Jul 2015

Aug 2016

Sep 2017

Sep 2018

Aug 2019

Jun 2026

0.00

100.00

99.67

64.29

0.00

0.29

0.00

6.42

Government

0.00

100.00

0.00

0.33

28.99

Hexagon Nutrition Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Hexagon Nutrition Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI